ClinicalTrials.gg
Drug

Enalapril clinical trials

Also written Vasotec and Renitec.

studies test it
66
open now
8
in phase 3
18
first study started
1992

How each study uses Enalapril is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study

Get an email when these change. Save the Enalapril studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Get alerts for these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your alerts, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your alerts. Stop any time.

Approvals

The first approval found in each region, with its record

United States
24 Dec 1985 · VASOTEC · NDA 018998 (FDA, Drugs@FDA)
European Union
15 Nov 2023 · Aqumeldi · EMEA/H/C/005731 (EMA)

From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out

How studies write it

Studies that test it under each name

Name

Enalapril
41
Enalapril Maleate
4

Brand

Vasotec
5
Renitec
2
naprilene
1
Renivace
1
epaned
1

In one entry with another drug

Given together, or one or the other

labetalol/hydralazine/enalapril
2
Enalapril plus Losartan
2

Studies by the year they started

64 studies that test it; most in 2009 (6)

Studies that test Enalapril, by start year
YearStudies
19921
19941
19971
20003
20033
20041
20054
20061
20073
20084
20096
20105
20111
20124
20132
20141
20153
20161
20175
20182
20191
20202
20211
20231
20241
20252
20264

By phase

A phase 1/2 study counts in both.

Early Phase 1
1
Phase 1
5
Phase 2
15
Phase 3
18
Phase 4
21
No phase
10

What it is tested for

Each study’s main condition, where its own words name it, so a study counts once.

Who runs them

Industry 11 · Other 55

Novartis Pharmaceuticals (3) · National Heart, Lung, and Blood Institute (NHLBI) (3) · Shenzhen Ausa Pharmed Co.,Ltd (3) · European Institute of Oncology (2) · Brigham and Women's Hospital (2) · University of Alberta (2) · National Center for Research Resources (NCRR) (2) · Chulalongkorn University (2)

Often tested with

Tested in the same studies.

Valsartan (6) · Folic Acid (5) · Lisinopril (5) · Losartan (5) · Candesartan (4) · Labetalol (3) · Hydralazine (3) · Sacubitril valsartan sodium hydrate (3)

Related medicines

As reviewed, each with the page that says it.

Coming up

From the study records. Dates are the sponsors’ own estimates and often move.

Tested against it · 1 phase 3 study under way

Enalapril is the comparator. A study of two new drugs counts under both.

Reaching primary completion within a year · 1, 1 in phase 3

Studies that test Enalapril, phase 3 first.

Studies

Open first, then newest update. How each study uses Enalapril is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.

Testing it · 66

See all 66 studies that test Enalapril →

Given beside what is tested · 3 — Enalapril is usual care or a partner of the new treatment
As the comparator · 22 — what is tested is compared with Enalapril

Showing 20 of 22.

Codes

What other systems call Enalapril · ClinicalTrials.gg INT007420

  • MeSH (NLM) D004656EnalaprilConfirmed ClinicalTrials.gov, NLM, Wikidata
  • UNII (FDA) 69PN84IO1AENALAPRILConfirmed FDA, NLM, Wikidata
  • RxNorm 3827Confirmed FDA, Wikidata
  • Wikidata Q422185enalaprilConfirmed FDA, NLM, Wikidata
  • NCI Thesaurus C62027EnalaprilOne source FDA
  • DrugBank DB00584One source Wikidata

Also registered as enalapril maleate (UNII 9O25354EPJ · RxNorm 203123).

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.